MedTrace Logo

Clinical Evaluation of MyDay™ and 1-DAY ACUVUE® TruEye®

NCT02388763 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2016-12-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the functional vision of 2 daily disposable silicone hydrogel contact lenses using Time Controlled Visual Acuity (TCVA) measurements at high luminance and high contrast after 10+/-3 days of wear post 3 hour exposure to a reduced humidity environment.

Conditions

  • Refractive Error

Interventions

DEVICE

Stenfilcon A contact lenses

Contact lenses worn during Period 1 or 2, as randomized

DEVICE

Narafilcon A contact lenses

Contact lenses worn during Period 1 or 2, as randomized

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Clinical Trial Manager, EMEA · Alcon, A Novartis Division

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2015-09-30
Completion
2015-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02388763 on ClinicalTrials.gov